Biomarkers In Medicine

Journal Title：Biomarkers In Medicine

Biomarkers are physical, functional or biochemical indicators of physiological or disease processes. These key indicators can provide vital information in determining disease prognosis, in predicting of response to therapies, adverse events and drug interactions, and in establishing baseline risk. The explosion of interest in biomarker research is driving the development of new predictive, diagnostic and prognostic products in modern medical practice, and biomarkers are also playing an increasingly important role in the discovery and development of new drugs. For the full utility of biomarkers to be realized, we require greater understanding of disease mechanisms, and the interplay between disease mechanisms, therapeutic interventions and the proposed biomarkers. However, in attempting to evaluate the pros and cons of biomarkers systematically, we are moving into new, challenging territory.

Biomarkers in Medicine (ISSN 1752-0363) is a peer-reviewed, rapid publication journal delivering commentary and analysis on the advances in our understanding of biomarkers and their potential and actual applications in medicine. The journal facilitates translation of our research knowledge into the clinic to increase the effectiveness of medical practice.

As the scientific rationale and regulatory acceptance for biomarkers in medicine and in drug development become more fully established, Biomarkers in Medicine provides the platform for all players in this increasingly vital area to communicate and debate all issues relating to the potential utility and applications.

Each issue includes a diversity of content to provide rounded coverage for the research professional. Articles include Guest Editorials, Interviews, Reviews, Research Articles, Perspectives, Priority Paper Evaluations, Special Reports, Case Reports, Conference Reports and Company Profiles. Review coverage is divided into themed sections according to area of therapeutic utility with some issues including themed sections on an area of topical interest.

Biomarkers in Medicine provides a platform for commentary and debate for all professionals with an interest in the identification of biomarkers, elucidation of their role and formalization and approval of their application in modern medicine. The audience for Biomarkers in Medicine includes academic and industrial researchers, clinicians, pathologists, clinical chemists and regulatory professionals.

生物标志物是生理或疾病过程的物理、功能或生化指标。这些关键指标可以在确定疾病预后、预测对治疗的反应、不良事件和药物相互作用以及确定基线风险方面提供重要信息。对生物标志物研究的兴趣激增，推动了现代医学实践中新的预测、诊断和预后产品的开发，生物标志物在新药的发现和开发中也发挥着越来越重要的作用。为了实现生物标志物的全部效用，我们需要更多地了解疾病机制，以及疾病机制、治疗干预和拟议的生物标志物之间的相互作用。然而，在尝试系统地评估生物标志物的优缺点时，我们正在进入新的、具有挑战性的领域。

Biomarkers in Medicine (ISSN 1752-0363) 是一本经过同行评审的快速出版期刊，就我们对生物标志物及其在医学中的潜在和实际应用的理解方面的进展进行评论和分析。该杂志有助于将我们的研究知识转化为临床，以提高医疗实践的有效性。

随着医学和药物开发中生物标志物的科学原理和监管接受度越来越高，医学生物标志物为这一日益重要的领域的所有参与者提供了一个平台，以交流和讨论与潜在效用和应用相关的所有问题.

每期都包含多种内容，以便为研究专业人士提供全面的报道。文章包括客座社论、访谈、评论、研究文章、观点、优先论文评估、专题报告、案例报告、会议报告和公司简介。审查范围根据治疗实用性领域分为主题部分，其中一些问题包括主题领域的主题部分。

医学生物标志物为所有对识别生物标志物、阐明其作用以及对其在现代医学中的应用的正式化和批准感兴趣的专业人士提供了一个评论和辩论平台。 Biomarkers in Medicine 的受众包括学术和工业研究人员、临床医生、病理学家、临床化学家和监管专业人士。

Biomarkers In Medicine创刊于2007年，由FUTURE MEDICINE LTD出版商出版，收稿方向涵盖医学 - 医学：研究与实验全领域，此期刊水平偏中等偏靠后，在所属细分领域中专业影响力一般，过审相对较易，如果您文章质量佳，选择此期刊，发表机率较高。平均审稿速度较慢,6-12周，影响因子指数2.479，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。